Friday, 23 Oct 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Clinical trial results
Finance
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Fineline Cube
Follow:
14720
Articles
Company
Drug
Harbour BioMed Concludes Phase I Study for HBM4003 in Advanced Melanoma
January 29, 2025
Company
Deals
Frontier Biotechnologies Partners with Yuyue Med for FB2001 Atomizer
January 29, 2025
Company
Deals
Harbour BioMed’s Nona Biosciences Licenses Antibody Platform to Kelun-Biotech
January 29, 2025
Company
Deals
ExoNeuglia Secures Angel Funding for iPSC-Based Cell Therapy
January 29, 2025
Company
Drug
Jacobio’s KRAS G12C Inhibitor JAB-21822 Receives Breakthrough Therapy Designation
January 29, 2025
Company
Drug
CSPC and Ascletis Get NMPA Approval for COVID-19 Drug Clinical Trials
January 30, 2025
Policy / Regulatory
24 Provinces Form Alliances for Volume-Based Procurement of Medical Consumables
January 29, 2025
Company
Deals
Yuanmai Cell Biotechnology Secures Angel Funding for Macrophage Immunotherapy
January 29, 2025
Company
Deals
Yantai Dongcheng Pharma Acquires Rights to 18F-APN-1607 from Aprinoia Therapeutics
January 29, 2025
Company
Deals
Shanghai Hantong Medtech Raises Angel Funding for Ultrasound Platform
January 29, 2025
Company
Deals
GenAssist Therapeutics Secures Series A Funding for Gene Therapy Development
January 29, 2025
Company
Drug
Hansoh’s Generic Firazyr Approved for Marketing in China by NMPA
January 29, 2025
1
2
…
1,099
1,100
1,101
1,102
1,103
…
1,226
1,227
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?
